波士顿科学 将以现金加股票方式收购美国医疗器械公司 Penumbra Inc 。每股对价为374美元,较Penumbra周三收盘价溢价约19%。
Penumbra股东可选择每股获得374美元现金,或兑换为3.8721股波士顿科学普通股。该交易的股权价值约为146亿美元,预计将在今年内完成。
波士顿科学 将以现金加股票方式收购美国医疗器械公司 Penumbra Inc 。每股对价为374美元,较Penumbra周三收盘价溢价约19%。
Penumbra股东可选择每股获得374美元现金,或兑换为3.8721股波士顿科学普通股。该交易的股权价值约为146亿美元,预计将在今年内完成。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.